Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Income towards Parent Company: 2021-2025

Historic Income towards Parent Company for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Sep 2025 value amounting to $7.4 million.

  • Arcutis Biotherapeutics' Income towards Parent Company rose 117.84% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.3 million, marking a year-over-year increase of 77.33%. This contributed to the annual value of -$140.0 million for FY2024, which is 46.58% up from last year.
  • As of Q3 2025, Arcutis Biotherapeutics' Income towards Parent Company stood at $7.4 million, which was up 146.64% from -$15.9 million recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Income towards Parent Company ranged from a high of $7.4 million in Q3 2025 and a low of -$107.7 million during Q3 2022.
  • Over the past 3 years, Arcutis Biotherapeutics' median Income towards Parent Company value was -$41.5 million (recorded in 2024), while the average stood at -$39.6 million.
  • Per our database at Business Quant, Arcutis Biotherapeutics' Income towards Parent Company plummeted by 88.70% in 2022 and then soared by 117.84% in 2025.
  • Quarterly analysis of 5 years shows Arcutis Biotherapeutics' Income towards Parent Company stood at -$71.3 million in 2021, then dropped by 1.03% to -$72.0 million in 2022, then increased by 7.96% to -$66.3 million in 2023, then soared by 83.72% to -$10.8 million in 2024, then spiked by 117.84% to $7.4 million in 2025.
  • Its last three reported values are $7.4 million in Q3 2025, -$15.9 million for Q2 2025, and -$25.1 million during Q1 2025.